F-1/A: Bon Natural Life Eyes $12 Million Raise Through Unit Offering

Bon Natural Life Limited aims to raise capital through offering ordinary and pre-funded units, each including shares and warrants.

Summary

• Bon Natural Life Limited is planning to raise up to $12 million through an offering of ordinary units and pre-funded units.
• Each ordinary unit includes one Class A ordinary share, one Series A warrant, and one Series B warrant.
• Each pre-funded unit includes one pre-funded warrant, one Series A warrant, and one Series B warrant.
• The assumed public offering price is $1.20 per unit.
• The company is registering up to 150,000,000 Class A Ordinary Shares underlying the warrants.
• The Series A warrant exercise price will reset after 30 trading days to 105% of the average of the three lowest VWAPs over the prior 20 trading days, but not below $0.24.
• The Series B warrant exercise price is $1.80, but holders can use a cashless exercise option.
• The company does not expect to receive cash from Series B warrant exercises due to the cashless option.
• The offering is on a best-efforts basis with no minimum amount required.
• The offering is expected to close by , 2025, but may be extended by 30 days.
• Net proceeds are estimated at $9.05 million and will be used for working capital, sales network expansion, research and development, and production capacity expansion.
• The company is a Cayman Islands holding company that conducts operations through PRC subsidiaries.
• The company is subject to risks associated with operating in China, including regulatory changes and government oversight.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.

Sentiment

Score: 5

Explanation: The document presents a mix of positive and negative aspects. While the company is attempting to raise capital and has plans for expansion, it also faces risks and challenges, including regulatory uncertainties and competition. The financial results show a decrease in net income, which is a negative signal.

Positives

• The company intends to use the net proceeds for working capital, to expand its sales network, research and development, and to expand its production capacity.

Negatives

• The company is subject to risks associated with operating in China, including regulatory changes and government oversight.
• The company does not expect to receive cash from Series B warrant exercises due to the cashless option.
• The offering is on a best-efforts basis with no minimum amount required.

Risks

• The company's operations are subject to complex and rapidly evolving laws and regulations in China.
• The Chinese government may exercise significant oversight and discretion over the conduct of the company's business.
• The company may fail to develop new clients and retain existing clients.
• The trading price for the company's Class A Ordinary Shares may fluctuate significantly.
• Certain existing shareholders have control over the company and their interests may not be aligned with the interests of other shareholders.
• The company does not expect to pay dividends in the foreseeable future.
• The company may face difficulties in protecting its interests, and the ability to protect rights through U.S. courts may be limited, because the company is incorporated under Cayman Islands law.

Future Outlook

The company intends to use the net proceeds from the offering for working capital, to expand its sales network, research and development, and to expand its production capacity.

Industry Context

The company operates in the natural products and ingredients industry, which is subject to changing consumer trends and preferences, especially with respect to weight management; targeted nutrition; energy, sports, and fitness; and other nutrition products.

Comparison to Industry Standards

• The company faces competition from Chenguang Biotech, Layn, Koninklijke DSM N.V., Symrise AG, and Givaudan SA.
• These companies have stronger capital resources and development capabilities.

Related Party Transactions

• As of September 30, 2024, the balance of due to related parties was comprised of the company's borrowings from related parties and was used for working capital during the company's normal course of business.
• The company's controlling shareholder, Mr. Yongwei Hu, pledged his personal bank savings as collateral to safeguard the company's borrowings from the banks and financial institutions.
• Mr. Yongwei Hu and his wife Ms. Jing Liu also jointly pledged their personal residence property to guarantee the company's certain loans.

Stakeholder Impact

• The offering will dilute existing shareholders' ownership.
• The company's ability to execute its business plan depends on the success of the offering.
• The company's future performance will impact the value of shareholders' investments.

Next Steps

• The company expects to hold an initial closing of the Offering on , 2025.
• The Offering will be terminated by , 2025, but may be extended by written agreement of the Company and the Placement Agent for a period of up to 30 days.

Key Dates